News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Koneru Mythili
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2023 |
4
| Koneru Mythili (Chief Medical Officer) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 51,918 options to buy
@ $2.14, valued at
$111.1k
|
|
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Koneru Mythili (Chief Medical Officer) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 140,000 options to buy
@ $3.29, valued at
$460.6k
|
|
| 03/12/2020 |
4
| Koneru Mythili (Chief Medical Officer) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 23,900 options to buy
@ $2.12, valued at
$50.7k
Granted 116,100 options to buy
@ $2.12, valued at
$246.1k
|
|
| 05/15/2019 |
3
| Koneru Mythili (Snr VP, Clinical Development) has filed a Form 3 on Marker Therapeutics, Inc. |
|
|